Internal Medicine · Marrero, LA
NPI
1346475506
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1151 Barataria Blvd Ste 3400
Marrero, LA, 70072
Phone (504) 265-8304
Groups this clinician bills Medicare through
Medicare paid, 2024
$361K
15,531 services
Medicare patients, 2024
277
Average age 73
Drug cost, 2024
$1.4M
9,511 prescriptions
Company payments, 2025
$611
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shibu Varughese was code 99233 (hospital e&m - subsequent), 2,317 times for 124 patients. In total Shibu Varughese billed 15,531 services in 91 codes, and Medicare paid $361K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 2,317 | 124 | $90.01 | $209K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,076 | 13 | $0.07 | $78.43 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 767 | 62 | $0.08 | $62.27 |
| 99214 Office E&M - Established | Office | 639 | 150 | $79.82 | $51K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 436 | 56 | $0.51 | $224 |
| 96372 Injection Administration | Office | 422 | 83 | $9.58 | $4,043 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 380 | 59 | $0.32 | $120 |
| 96361 Intravenous Infusion, Hydration | Office | 252 | 21 | $9.04 | $2,277 |
| 99239 Hospital Discharge Management | Facility | 223 | 122 | $87.10 | $19K |
| 96367 Intravenous Infusion, Hydration | Office | 198 | 14 | $20.78 | $4,115 |
| 99223 Hospital E&M - Initial | Facility | 187 | 101 | $130.29 | $24K |
| 96365 Intravenous Infusion, Hydration | Office | 168 | 25 | $44.74 | $7,517 |
| 96366 Intravenous Infusion, Hydration | Office | 162 | 14 | $15.02 | $2,434 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 65 | 35 | $47.97 | $3,118 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 60 | 35 | $36.61 | $2,197 |
By year: 2022 $374K for 15,509 services; 2023 $386K for 11,200 services; 2024 $361K for 15,531 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shibu Varughese prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 384 prescriptions and refills. In total Shibu Varughese wrote 9,511 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 384 | 670 | 149 | $15K |
| Gabapentin Generic | 274 | 499 | 85 | $3,956 |
| Methylprednisolone Generic | 250 | 250 | 174 | $1,907 |
| Atorvastatin Calcium Generic | 244 | 618 | 105 | $1,511 |
| Losartan Potassium Generic | 231 | 583 | 95 | $1,280 |
| Amlodipine Besylate Generic | 227 | 560 | 95 | $798 |
| Tramadol Hcl Generic | 226 | 226 | 56 | $1,253 |
| Rosuvastatin Calcium Generic | 226 | 558 | 94 | $1,355 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 215 | 215 | 46 | $4,573 |
| Pantoprazole Sodium Generic | 190 | 426 | 83 | $1,248 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 190 | 190 | 26 | $4,602 |
| Azithromycin Generic | 188 | 188 | 145 | $955 |
| Trazodone Hcl Generic | 173 | 276 | 53 | $1,057 |
| Hydrochlorothiazide Generic | 152 | 412 | 63 | $639 |
| Alprazolam Generic | 137 | 142 | 32 | $814 |
Brand drugs: 1,014 claims; generic drugs: 8,451 claims; opioid claims: 829.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shibu Varughese $611 ($611 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $67.43.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $67.43 |
| Novo Nordisk Inc NVO | 3 | $59.38 |
| Merck Sharp & Dohme LLC MRK | 2 | $54.39 |
| Xeris Pharmaceuticals, Inc. | 3 | $52.03 |
| Celgene Corporation BMY | 2 | $47.09 |
| Dexcom, Inc. DXCM | 2 | $46.84 |
| Corcept Therapeutics CORT | 2 | $45.44 |
| Janssen Biotech, Inc. JNJ | 2 | $43.3 |
| Lilly USA, LLC LLY | 2 | $42.35 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $32.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.